Similar Papers

Paper Title
Journal
Date
Author
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
N Colombo ... C Sessa
Annals of Oncology | VOL. 22
N Colombo, et. al.N Colombo ... C Sessa
01 Sep 2011
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
Willem Jan Van Weelden ...
American Journal of Obstetrics and Gynecology | VOL. 225
Willem Jan Van Weelden, et. al.Willem Jan Van Weelden ...
19 May 2021
Decision-making preferences in patients with advanced and recurrent endometrial cancer (502)
Sarah Ackroyd ... Nita Lee
Gynecologic Oncology | VOL. 166
Sarah Ackroyd, et. al.Sarah Ackroyd ... Nita Lee
01 Aug 2022
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Oaknin ... N Colombo
Annals of Oncology | VOL. 33
A Oaknin, et. al.A Oaknin ... N Colombo
08 Jun 2022
View more papers

More From: CA: A Cancer Journal for Clinicians

Paper Title
Journal
Date
Author
Cancer statistics, 2025.
Rebecca L Siegel ... Ahmedin Jemal
CA: a cancer journal for clinicians | VOL. -
Rebecca L Siegel, et. al.Rebecca L Siegel ... Ahmedin Jemal
16 Jan 2025
Cancer statistics, 2025: A hinge moment for optimism to morph into hope?
Benjamin W Corn ... David B Feldman
CA: A Cancer Journal for Clinicians | VOL. -
Benjamin W Corn, et. al.Benjamin W Corn ... David B Feldman
16 Jan 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.
Chadi Hage Chehade ... Neeraj Agarwal
CA: a cancer journal for clinicians | VOL. -
Chadi Hage Chehade, et. al.Chadi Hage Chehade ... Neeraj Agarwal
10 Jan 2025
Highlighting American Cancer Society-funded research in CA: A Cancer Journal for Clinicians.
Don S Dizon ... Christina M Annunziata
CA: a cancer journal for clinicians | VOL. -
Don S Dizon, et. al.Don S Dizon ... Christina M Annunziata
09 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.